Literature DB >> 15183516

Differential expression of brain-derived neurotrophic factor transcripts after pilocarpine-induced seizure-like activity is related to mode of Ca2+ entry.

F R Poulsen1, J Lauterborn, J Zimmer, C M Gall.   

Abstract

Activity-dependent brain-derived neurotrophic factor (BDNF) expression is Ca2+-dependent, yet little is known about the Ca2+ channel contributions that might direct selective expression of the multiple BDNF transcripts. Here, effects of pilocarpine-induced seizure activity on total BDNF expression and on the individual sensitivity of BDNF transcripts to glutamate receptor and Ca2+ channel blockers were evaluated using hippocampal slice cultures and in situ hybridization of transcript-specific cRNA probes directed against mRNAs for the four 5' exons (I-IV) of the BDNF gene. mRNAs for nerve growth factor (NGF) and tyrosine kinase B (trkB) also were studied. Pilocarpine (5 mM) induced a dose- and time-dependent increase in total BDNF (exon V) mRNA expression in the dentate granule cells and CA3-CA1 pyramidal cells with maximal effects at 6 and 24 h, respectively. Increases were blocked by co-treatment with the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid/kainate 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX: 25 microM) and the N-methyl-d-aspartic acid receptor antagonist 2-amino-5-phosphonovaleric acid (APV; 25 microM), whereas the L-type voltage sensitive Ca2+ channel blocker nifedipine (20 microM) was without detectable effect. Maximal NGF and trkB mRNA expression was induced by pilocarpine at 4 and 12 h, respectively. For the individual BDNF transcripts, APV blocked pilocarpine-induced increases in transcript II, whereas nifedipine blocked increases in transcripts I and III. Transcript IV levels were not altered by treatment. These results indicate that transcript II makes the greatest contribution to pilocarpine effects on total BDNF mRNA content in this model and provides evidence for regional and Ca2+ channel-specific differences in activity-dependent regulation of the different BDNF transcripts in hippocampus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183516     DOI: 10.1016/j.neuroscience.2004.04.008

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

Review 1.  Biological functions and transcriptional targets of CaRF in neurons.

Authors:  Anne E West
Journal:  Cell Calcium       Date:  2011-05-11       Impact factor: 6.817

2.  Morphology and synaptic input of substance P receptor-immunoreactive interneurons in control and epileptic human hippocampus.

Authors:  K Tóth; L Wittner; Z Urbán; W K Doyle; G Buzsáki; R Shigemoto; T F Freund; Z Maglóczky
Journal:  Neuroscience       Date:  2006-11-13       Impact factor: 3.590

3.  Immunohistochemical evaluation of the protein expression of nerve growth factor and its TrkA receptor in rat limbic regions following electroshock seizures.

Authors:  Giuseppe Conti; Karen Gale; Alexei Kondratyev
Journal:  Neurosci Res       Date:  2009-07-09       Impact factor: 3.304

4.  Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signaling events in the mouse hippocampus and prefrontal cortex.

Authors:  Janne Koskimäki; Nobuaki Matsui; Juzoh Umemori; Tomi Rantamäki; Eero Castrén
Journal:  Cell Mol Neurobiol       Date:  2014-09-10       Impact factor: 5.046

5.  Seizure activity involved in the up-regulation of BDNF mRNA expression by activation of central mu opioid receptors.

Authors:  H N Zhang; M C Ko
Journal:  Neuroscience       Date:  2009-03-19       Impact factor: 3.590

6.  HuD interacts with Bdnf mRNA and is essential for activity-induced BDNF synthesis in dendrites.

Authors:  Filip Vanevski; Baoji Xu
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

7.  Expression and Dendritic Trafficking of BDNF-6 Splice Variant are Impaired in Knock-In Mice Carrying Human BDNF Val66Met Polymorphism.

Authors:  Alessandra Mallei; Gabriele Baj; Alessandro Ieraci; Stefano Corna; Laura Musazzi; Francis S Lee; Enrico Tongiorgi; Maurizio Popoli
Journal:  Int J Neuropsychopharmacol       Date:  2015-06-24       Impact factor: 5.176

8.  Dysregulation of Alternative Poly-adenylation as a Potential Player in Autism Spectrum Disorder.

Authors:  Krzysztof J Szkop; Peter I C Cooke; Joanne A Humphries; Viktoria Kalna; David S Moss; Eugene F Schuster; Irene Nobeli
Journal:  Front Mol Neurosci       Date:  2017-09-13       Impact factor: 5.639

9.  Exon expression profiling reveals stimulus-mediated exon use in neural cells.

Authors:  Adrienne E McKee; Nicola Neretti; Luis E Carvalho; Clifford A Meyer; Edward A Fox; Alexander S Brodsky; Pamela A Silver
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.